Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,279,923 papers from all fields of science
Search
Sign In
Create Free Account
MAPK10 wt Allele
Known as:
JNK3A
, PRKM10
, FLJ12099
Expand
Human MAPK10 wild-type allele is located within 4q22.1-q23 and is approximately 344 kb in length. This allele, which encodes mitogen-activated…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
19 relations
4q22.1-q23
Adipocytokine Signaling Pathway
Cell Cycle Control
Cell Proliferation
Expand
Broader (1)
MAPK10 gene
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2011
Review
2011
JNK3 as a therapeutic target for neurodegenerative diseases.
X. Antoniou
,
M. Falconi
,
D. Di Marino
,
T. Borsello
Journal of Alzheimer's Disease
2011
Corpus ID: 10373902
c-Jun N-terminal kinases (JNKs) and in particular JNK3 the neuronal specific isoform, have been recognized as important enzymes…
Expand
Highly Cited
2010
Highly Cited
2010
p75 Neurotrophin Receptor-mediated Apoptosis in Sympathetic Neurons Involves a Biphasic Activation of JNK and Up-regulation of Tumor Necrosis Factor-α-converting Enzyme/ADAM17*
R. Kenchappa
,
Chhavy Tep
,
+4 authors
B. Carter
Journal of Biological Chemistry
2010
Corpus ID: 22835619
During the development of the sympathetic nervous system, the p75 neurotrophin receptor (p75NTR) has a dual function: promoting…
Expand
Highly Cited
2005
Highly Cited
2005
Physiological Regulation of the β-Amyloid Precursor Protein Signaling Domain by c-Jun N-Terminal Kinase JNK3 during Neuronal Differentiation
W. Kimberly
,
Jessica B. Zheng
,
T. Town
,
R. Flavell
,
D. Selkoe
Journal of Neuroscience
2005
Corpus ID: 7667336
β-Amyloid precursor protein (APP) is a conserved and ubiquitous transmembrane glycoprotein strongly implicated in the…
Expand
Review
2004
Review
2004
Targeting JNK3 for the treatment of neurodegenerative disorders.
L. Resnick
,
M. Fennell
Drug Discovery Today
2004
Corpus ID: 38113389
Highly Cited
2003
Highly Cited
2003
The structure of JNK3 in complex with small molecule inhibitors: structural basis for potency and selectivity.
G. Scapin
,
Sangita Patel
,
Jeanmarie Lisnock
,
J. W. Becker
,
P. Lograsso
Chemistry and Biology
2003
Corpus ID: 37565033
2002
2002
JNK3 contributes to c‐jun induction and apoptosis in 4‐hydroxynonenal‐treated sympathetic neurons
Shane R. Bruckner
,
S. Estus
Journal of Neuroscience Research
2002
Corpus ID: 5986365
4‐Hydroxynoneal (HNE), an end product of lipid peroxidation, induces apoptosis in many cell types, including neural cells. HNE…
Expand
Highly Cited
2001
Highly Cited
2001
Arsenic induces apoptosis in rat cerebellar neurons via activation of JNK3 and p38 MAP kinases.
U. Namgung
,
Z. Xia
Toxicology and Applied Pharmacology
2001
Corpus ID: 23330734
Primary cultures of rat cerebellar neurons were used to study mechanisms of arsenic neurotoxicity. Exposure to 5, 10, or 15…
Expand
Highly Cited
2001
Highly Cited
2001
Identification of a Motif in the Carboxyl Terminus of β-Arrestin2 Responsible for Activation of JNK3*
W. Miller
,
P. McDonald
,
S. Cai
,
Michael E. Field
,
R. Davis
,
R. Lefkowitz
Journal of Biological Chemistry
2001
Corpus ID: 13256014
Accumulating evidence indicates that the β-arrestins act as scaffold molecules that couple G-protein-coupled receptors to mitogen…
Expand
Highly Cited
1998
Highly Cited
1998
Crystal structure of JNK3: a kinase implicated in neuronal apoptosis.
Xiaoling Xie
,
Yong Gu
,
+6 authors
M. Su
Structure
1998
Corpus ID: 25783135
Highly Cited
1997
Highly Cited
1997
JNK1, JNK2 and JNK3 are p53 N-terminal serine 34 kinases
M. C. Hu
,
W. Qiu
,
You-Ping Wang
Oncogene
1997
Corpus ID: 27483735
The function of the tumor suppressor protein p53 is modulated by post-translational events, primarily by phosphorylation. p53 is…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE